BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37191295)

  • 1. Young apheresis platelet donors show significant and sustained growth over the last decade in the US, 2010-2019: A favorable sign of the resiliency of the platelet supply.
    Lasky B; Singh U; Young PP
    Transfusion; 2023 Jul; 63(7):1333-1343. PubMed ID: 37191295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections.
    Sloand EM; Yu M; Klein HG
    Transfusion; 1996; 36(11-12):955-9. PubMed ID: 8937403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained decreases in platelet count associated with multiple, regular plateletpheresis donations.
    Lazarus EF; Browning J; Norman J; Oblitas J; Leitman SF
    Transfusion; 2001 Jun; 41(6):756-61. PubMed ID: 11399815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of a switch to a 100% apheresis platelet supply for patients and for blood donors: a risk benefit analysis.
    Thiele T; Alt-Mayer T; Greinacher A; Bux J
    Vox Sang; 2016 Nov; 111(4):350-356. PubMed ID: 27432635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discussion on the recruitment strategy for apheresis platelet donors in Chongqing during a public health emergency
    Cheng Y; Xie C; Tian Y; Wang F; Liu X; Cheng D
    Front Public Health; 2024; 12():1365433. PubMed ID: 38651129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of immediate adverse donation reactions on the return of volunteers undergoing platelet apheresis.
    de Farias CLG; Bassolli L; Mendrone-Junior A; de Araújo Arrais C; Duran A; Rocha V; de Almeida-Neto C
    Transfus Apher Sci; 2022 Aug; 61(4):103424. PubMed ID: 35346602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The apheresis platelet donation was increased after a nationwide ban on family/replacement donation in China.
    Chen J; Zhou G; Fu X; Li S; Li Y; Kang J; Chen H; Zhou L; Fu Y
    BMC Public Health; 2021 Apr; 21(1):819. PubMed ID: 33926409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A questionnaire: will plateletpheresis donors accept multicomponent donation?
    Qendro I; Moog R; Müller N
    Transfus Apher Sci; 2002 Oct; 27(2):95-9. PubMed ID: 12350055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of platelet yield, donor's characteristic and apheresis instruments in China.
    Yin G; Xu J; Shen Z; Wang Y; Zhu F; Lv H
    Transfus Apher Sci; 2013 Dec; 49(3):608-12. PubMed ID: 23978555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Indications and Adverse Reactions of Platelet Apheresis.
    Amanat ST; Shakoor HA; Raza M; Khan N; Rauf A
    J Coll Physicians Surg Pak; 2015 Jun; 25(6):403-6. PubMed ID: 26100990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
    Woodall WJ; Nguyen VQ; Tran MH
    J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of double- and triple-apheresis platelet product donation on apheresis donor platelet and white blood cell counts.
    Richa E; Krueger P; Burgstaler EA; Bryant SC; Winters JL
    Transfusion; 2008 Jul; 48(7):1325-32. PubMed ID: 18346017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006.
    Eder AF; Dy BA; Kennedy JM; Notari Iv EP; Strupp A; Wissel ME; Reddy R; Gibble J; Haimowitz MD; Newman BH; Chambers LA; Hillyer CD; Benjamin RJ
    Transfusion; 2008 Sep; 48(9):1809-19. PubMed ID: 18631167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge and attitudes of apheresis donors regarding apheresis blood donation.
    Tarlabelen Karaytuğ E; Boyraz S
    Transfus Med; 2023 Feb; 33(1):39-48. PubMed ID: 35633143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current state of the platelet supply in the US and proposed options to decrease the risk of critical shortages.
    Stubbs JR; Homer MJ; Silverman T; Cap AP
    Transfusion; 2021 Jan; 61(1):303-312. PubMed ID: 33098328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a transfusion-related acute lung injury reduction strategy on apheresis platelet collections.
    Williams D; Rao M; Carey P
    J Clin Apher; 2012; 27(4):205-11. PubMed ID: 22535678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of the levels of reticulated platelets after plateletpheresis to monitor activity of thrombopoiesis.
    Stohlawetz P; Stiegler G; Jilma B; Dettke M; Höcker P; Panzer S
    Transfusion; 1998 May; 38(5):454-8. PubMed ID: 9633558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Namibia's transition from whole blood-derived pooled platelets to single-donor apheresis platelet collections.
    Pitman JP; Basavaraju SV; Shiraishi RW; Wilkinson R; von Finckenstein B; Lowrance DW; Marfin AA; Postma M; Mataranyika M; Smit Sibinga CT
    Transfusion; 2015 Jul; 55(7):1685-92. PubMed ID: 25727921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plateletpheresis in 90- to 110-pound donors using the CS-3000 blood cell separator.
    Buchholz DH; Squires JE; Herman JH; Ng AT; Anderson JK; Hedberg SL
    Transfusion; 1997 Jul; 37(7):715-8. PubMed ID: 9225935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.